IRIDEX Corporation (IRIX)
USD 0.88
(-7.25%)
USD 0.88
(-7.25%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 9.9 Million USD | -6.62% |
| 2022 | 10.6 Million USD | 39.32% |
| 2021 | 7.61 Million USD | 33.25% |
| 2020 | 5.71 Million USD | -30.1% |
| 2019 | 8.17 Million USD | -7.05% |
| 2018 | 8.79 Million USD | -6.26% |
| 2017 | 9.38 Million USD | -19.43% |
| 2016 | 11.64 Million USD | 4.84% |
| 2015 | 11.1 Million USD | 21.79% |
| 2014 | 9.11 Million USD | -14.01% |
| 2013 | 10.6 Million USD | 31.99% |
| 2012 | 8.03 Million USD | 20.66% |
| 2011 | 6.65 Million USD | -27.71% |
| 2010 | 9.21 Million USD | 2.37% |
| 2009 | 8.99 Million USD | -22.72% |
| 2008 | 11.64 Million USD | -27.07% |
| 2007 | 15.96 Million USD | 68.09% |
| 2006 | 9.49 Million USD | 10.53% |
| 2005 | 8.59 Million USD | -3.68% |
| 2004 | 8.92 Million USD | 2.3% |
| 2003 | 8.72 Million USD | -18.69% |
| 2002 | 10.72 Million USD | -14.62% |
| 2001 | 12.56 Million USD | 29.23% |
| 2000 | 9.72 Million USD | 33.97% |
| 1999 | 7.25 Million USD | 11.63% |
| 1998 | 6.5 Million USD | 62.5% |
| 1997 | 4 Million USD | 110.53% |
| 1996 | 1.9 Million USD | 46.15% |
| 1995 | 1.3 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 11 Million USD | 11.07% |
| 2024 Q2 | 11.12 Million USD | 1.1% |
| 2023 Q4 | 9.9 Million USD | -2.1% |
| 2023 Q2 | 11.12 Million USD | -1.0% |
| 2023 Q1 | 11.24 Million USD | 5.97% |
| 2023 Q3 | 10.11 Million USD | -9.08% |
| 2023 FY | 9.9 Million USD | -6.62% |
| 2022 FY | 10.6 Million USD | 39.32% |
| 2022 Q1 | 9.09 Million USD | 19.4% |
| 2022 Q2 | 10.17 Million USD | 11.93% |
| 2022 Q3 | 10.76 Million USD | 5.79% |
| 2022 Q4 | 10.6 Million USD | -1.46% |
| 2021 Q1 | 7.04 Million USD | 23.24% |
| 2021 Q4 | 7.61 Million USD | -13.39% |
| 2021 FY | 7.61 Million USD | 33.25% |
| 2021 Q3 | 8.79 Million USD | 10.41% |
| 2021 Q2 | 7.96 Million USD | 13.06% |
| 2020 Q3 | 7 Million USD | -10.74% |
| 2020 FY | 5.71 Million USD | -30.1% |
| 2020 Q1 | 8.15 Million USD | -0.2% |
| 2020 Q2 | 7.84 Million USD | -3.81% |
| 2020 Q4 | 5.71 Million USD | -18.42% |
| 2019 Q2 | 8.97 Million USD | 3.14% |
| 2019 FY | 8.17 Million USD | -7.05% |
| 2019 Q4 | 8.17 Million USD | -8.12% |
| 2019 Q3 | 8.89 Million USD | -0.87% |
| 2019 Q1 | 8.7 Million USD | -1.06% |
| 2018 Q3 | 8.72 Million USD | -4.05% |
| 2018 Q4 | 8.79 Million USD | 0.79% |
| 2018 Q2 | 9.09 Million USD | -2.29% |
| 2018 FY | 8.79 Million USD | -6.26% |
| 2018 Q1 | 9.3 Million USD | -0.8% |
| 2017 Q1 | 11.72 Million USD | 0.73% |
| 2017 Q3 | 10.66 Million USD | -6.31% |
| 2017 Q4 | 9.38 Million USD | -12.07% |
| 2017 FY | 9.38 Million USD | -19.43% |
| 2017 Q2 | 11.38 Million USD | -2.9% |
| 2016 Q3 | 12.67 Million USD | 4.42% |
| 2016 Q2 | 12.14 Million USD | 8.97% |
| 2016 Q1 | 11.14 Million USD | 0.32% |
| 2016 FY | 11.64 Million USD | 4.84% |
| 2016 Q4 | 11.64 Million USD | -8.16% |
| 2015 Q4 | 11.1 Million USD | -0.7% |
| 2015 Q2 | 10.17 Million USD | 3.22% |
| 2015 Q3 | 11.18 Million USD | 9.96% |
| 2015 FY | 11.1 Million USD | 21.79% |
| 2015 Q1 | 9.85 Million USD | 8.06% |
| 2014 Q1 | 9.85 Million USD | -7.04% |
| 2014 Q2 | 9.75 Million USD | -1.07% |
| 2014 FY | 9.11 Million USD | -14.01% |
| 2014 Q3 | 9.6 Million USD | -1.53% |
| 2014 Q4 | 9.11 Million USD | -5.05% |
| 2013 Q3 | 9.99 Million USD | 11.83% |
| 2013 Q1 | 8.14 Million USD | 1.39% |
| 2013 Q2 | 8.94 Million USD | 9.73% |
| 2013 FY | 10.6 Million USD | 31.99% |
| 2013 Q4 | 10.6 Million USD | 6.07% |
| 2012 FY | 8.03 Million USD | 20.66% |
| 2012 Q4 | 8.03 Million USD | 6.54% |
| 2012 Q3 | 7.54 Million USD | 0.04% |
| 2012 Q2 | 7.53 Million USD | 7.12% |
| 2012 Q1 | 7.03 Million USD | 5.69% |
| 2011 FY | 6.65 Million USD | -27.71% |
| 2011 Q1 | 9.19 Million USD | -0.16% |
| 2011 Q4 | 6.65 Million USD | -34.56% |
| 2011 Q3 | 10.17 Million USD | 0.07% |
| 2011 Q2 | 10.16 Million USD | 10.57% |
| 2010 Q4 | 9.21 Million USD | -5.83% |
| 2010 Q2 | 9.47 Million USD | 4.93% |
| 2010 Q1 | 9.03 Million USD | 0.39% |
| 2010 Q3 | 9.78 Million USD | 3.2% |
| 2010 FY | 9.21 Million USD | 2.37% |
| 2009 Q4 | 8.99 Million USD | -6.9% |
| 2009 Q2 | 10.1 Million USD | -9.49% |
| 2009 FY | 8.99 Million USD | -22.72% |
| 2009 Q1 | 11.16 Million USD | -4.12% |
| 2009 Q3 | 9.66 Million USD | -4.34% |
| 2008 Q4 | 11.64 Million USD | -13.92% |
| 2008 Q2 | 15.19 Million USD | -5.1% |
| 2008 FY | 11.64 Million USD | -27.07% |
| 2008 Q1 | 16.01 Million USD | 0.29% |
| 2008 Q3 | 13.52 Million USD | -10.99% |
| 2007 Q3 | 13.25 Million USD | -5.17% |
| 2007 Q4 | 15.96 Million USD | 20.51% |
| 2007 FY | 15.96 Million USD | 68.09% |
| 2007 Q1 | 13.24 Million USD | 39.43% |
| 2007 Q2 | 13.97 Million USD | 5.5% |
| 2006 Q4 | 9.49 Million USD | 11.37% |
| 2006 FY | 9.49 Million USD | 10.53% |
| 2006 Q1 | 8.68 Million USD | 1.08% |
| 2006 Q2 | 8.87 Million USD | 2.19% |
| 2006 Q3 | 8.52 Million USD | -3.92% |
| 2005 FY | 8.59 Million USD | -3.68% |
| 2005 Q3 | 9.32 Million USD | 4.08% |
| 2005 Q4 | 8.59 Million USD | -7.86% |
| 2005 Q1 | 9.51 Million USD | 6.6% |
| 2005 Q2 | 8.96 Million USD | -5.78% |
| 2004 Q3 | 8.4 Million USD | 1.31% |
| 2004 Q4 | 8.92 Million USD | 6.15% |
| 2004 Q2 | 8.29 Million USD | -2.05% |
| 2004 Q1 | 8.47 Million USD | -2.88% |
| 2004 FY | 8.92 Million USD | 2.3% |
| 2003 Q3 | 9.44 Million USD | -9.2% |
| 2003 Q4 | 8.72 Million USD | -7.68% |
| 2003 Q2 | 10.4 Million USD | -2.0% |
| 2003 FY | 8.72 Million USD | -18.69% |
| 2003 Q1 | 10.61 Million USD | -1.02% |
| 2002 FY | 10.72 Million USD | -14.62% |
| 2002 Q1 | 12.36 Million USD | -1.6% |
| 2002 Q2 | 11.83 Million USD | -4.23% |
| 2002 Q3 | 11.71 Million USD | -1.01% |
| 2002 Q4 | 10.72 Million USD | -8.48% |
| 2001 Q2 | 10.45 Million USD | 12.76% |
| 2001 Q3 | 12.05 Million USD | 15.37% |
| 2001 Q4 | 12.56 Million USD | 4.19% |
| 2001 FY | 12.56 Million USD | 29.23% |
| 2001 Q1 | 9.26 Million USD | -4.66% |
| 2000 Q4 | 9.72 Million USD | 7.83% |
| 2000 Q1 | 7.35 Million USD | 1.3% |
| 2000 Q2 | 8.32 Million USD | 13.28% |
| 2000 Q3 | 9.01 Million USD | 8.28% |
| 2000 FY | 9.72 Million USD | 33.97% |
| 1999 Q1 | 7.2 Million USD | 10.77% |
| 1999 FY | 7.25 Million USD | 11.63% |
| 1999 Q2 | 7.3 Million USD | 1.39% |
| 1999 Q3 | 7.2 Million USD | -1.37% |
| 1999 Q4 | 7.25 Million USD | 0.78% |
| 1998 Q3 | 6.8 Million USD | 11.48% |
| 1998 FY | 6.5 Million USD | 62.5% |
| 1998 Q1 | 4.5 Million USD | 12.5% |
| 1998 Q2 | 6.1 Million USD | 35.56% |
| 1998 Q4 | 6.5 Million USD | -4.41% |
| 1997 FY | 4 Million USD | 110.53% |
| 1997 Q1 | 2.1 Million USD | 10.53% |
| 1997 Q2 | 2.6 Million USD | 23.81% |
| 1997 Q3 | 3.3 Million USD | 26.92% |
| 1997 Q4 | 4 Million USD | 21.21% |
| 1996 Q3 | 2.3 Million USD | 21.05% |
| 1996 Q4 | 1.9 Million USD | -17.39% |
| 1996 FY | 1.9 Million USD | 46.15% |
| 1996 Q2 | 1.9 Million USD | 0.0% |
| 1995 Q4 | 1.3 Million USD | 0.0% |
| 1995 FY | 1.3 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -199.275% |
| BrainsWay Ltd. | 3.71 Million USD | -166.505% |
| Cerus Corporation | 39.86 Million USD | 75.153% |
| Envoy Medical, Inc. | 1.4 Million USD | -605.556% |
| electroCore, Inc. | 2.16 Million USD | -358.611% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -2067.615% |
| IceCure Medical Ltd | 2.27 Million USD | -335.429% |
| Inogen, Inc. | 21.84 Million USD | 54.643% |
| OrthoPediatrics Corp. | 105.85 Million USD | 90.642% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -3463.309% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -990599900.0% |
| MaxCyte, Inc. | 12.22 Million USD | 18.996% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -473.7% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -6232.95% |
| Orthofix Medical Inc. | 222.16 Million USD | 95.541% |
| PAVmed Inc | 1.01 Million USD | -874.042% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 50.373% |
| RxSight, Inc. | 17.42 Million USD | 43.138% |
| Sight Sciences, Inc. | 7.84 Million USD | -26.207% |
| SI-BONE, Inc. | 20.24 Million USD | 51.079% |
| TELA Bio, Inc. | 13.16 Million USD | 24.738% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 66.128% |
| Vivos Therapeutics, Inc. | 1.00 USD | -990599900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | -131.557% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -4206.957% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -320.458% |
| CVRx, Inc. | 10.98 Million USD | 9.806% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -2439.505% |
| Bioventus Inc. | 91.33 Million USD | 89.154% |
| Venus Concept Inc. | 28.67 Million USD | 65.455% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -289.234% |
| LivaNova PLC | 147.88 Million USD | 93.302% |
| 908 Devices Inc. | 14.93 Million USD | 33.686% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 92.761% |
| Nemaura Medical Inc. | 1.75 Million USD | -464.492% |
| NeuroPace, Inc. | 11.21 Million USD | 11.664% |
| LENSAR, Inc. | 15.68 Million USD | 36.86% |
| Apyx Medical Corporation | 9.92 Million USD | 0.171% |
| Cutera, Inc. | 72.1 Million USD | 86.261% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -270.595% |
| BioSig Technologies, Inc. | -103 Thousand USD | 9717.476% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 78.644% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | -25.218% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 97.457% |
| Axonics, Inc. | 79.94 Million USD | 87.608% |
| Outset Medical, Inc. | 49.21 Million USD | 79.872% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 75.083% |
| IRadimed Corporation | 12.82 Million USD | 22.737% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -1210.317% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -3645.08% |
| Telesis Bio, Inc. | 4.02 Million USD | -146.112% |
| Viemed Healthcare, Inc. | 4.6 Million USD | -115.146% |
| Varex Imaging Corporation | 277.5 Million USD | 96.43% |
| Quipt Home Medical Corp. | 18.32 Million USD | 45.945% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 40.835% |
| Dynatronics Corporation | 5.59 Million USD | -77.083% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | -164.796% |
| Semler Scientific, Inc. | 445 Thousand USD | -2126.067% |
| InMode Ltd. | 45.09 Million USD | 78.033% |
| Bruker Corporation | 968.3 Million USD | 98.977% |
| Cytosorbents Corporation | 3.68 Million USD | -169.175% |
| DexCom, Inc. | 559.6 Million USD | 98.23% |
| Align Technology, Inc. | 296.9 Million USD | 96.664% |
| Viveve Medical, Inc. | 1.47 Million USD | -572.962% |
| ZimVie Inc. | 79.6 Million USD | 87.555% |
| Movano Inc. | 1.51 Million USD | -554.726% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 83.728% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -6232.95% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 93.728% |
| Profound Medical Corp. | 6.95 Million USD | -42.466% |
| Insulet Corporation | 402.6 Million USD | 97.539% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | 33.243% |
| iCAD, Inc. | 917 Thousand USD | -980.262% |
| Nuwellis, Inc. | 1.99 Million USD | -396.044% |
| Biotricity, Inc. | 1.87 Million USD | -427.083% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 29.106% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -370.37% |
| PAVmed Inc. | 1.01 Million USD | -874.042% |
| BIOLASE, Inc. | 11.43 Million USD | 13.356% |
| Beyond Air, Inc. | 2.12 Million USD | -365.726% |
| FONAR Corporation | 2.71 Million USD | -264.803% |
| AxoGen, Inc. | 23.02 Million USD | 56.968% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 56.026% |
| Inari Medical, Inc. | 42.9 Million USD | 76.909% |
| UFP Technologies, Inc. | 70.19 Million USD | 85.887% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -1474.433% |
| Tenon Medical, Inc. | 554 Thousand USD | -1688.087% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -495.053% |
| AdaptHealth Corp. | 113.64 Million USD | 91.283% |
| Sintx Technologies, Inc. | 888 Thousand USD | -1015.541% |
| NanoVibronix, Inc. | 2.73 Million USD | -262.592% |
| Quanterix Corporation | 22.36 Million USD | 55.708% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 33.279% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 82.522% |
| TransMedics Group, Inc. | 44.23 Million USD | 77.606% |
| ReWalk Robotics Ltd. | 5.65 Million USD | -75.234% |
| NeuroMetrix, Inc. | 1.55 Million USD | -535.233% |
| Hyperfine, Inc. | 6.58 Million USD | -50.501% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 87.608% |
| Biomerica, Inc. | 2.37 Million USD | -316.919% |
| Bone Biologics Corporation | -328.84 Thousand USD | 3112.371% |
| AVITA Medical, Inc. | 3.12 Million USD | -217.356% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 66.843% |